DISULFIRAM

DISULFIRAM was reported 1135 times

DISULFIRAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROTEIN ALBUMIN RATIO DECREASED 3 0.1364
1 DEATH OF PARENT 1 0.0769
2 HEPATITIS NON-A NON-B 1 0.0588
3 PSEUDOLOGIA 1 0.0556
4 LABELLED DRUG-ALCOHOL INTERACTION ISSUE 1 0.0526
5 MILK-ALKALI SYNDROME 26 0.0497
6 LABELLED DRUG-FOOD INTERACTION ISSUE 6 0.0353
7 ALCOHOL INTOLERANCE 21 0.0296
8 CERULOPLASMIN INCREASED 1 0.0286
9 INJECTION SITE ISCHAEMIA 2 0.0278
10 SEPTIC PULMONARY EMBOLISM 5 0.0256
11 TOXIC OPTIC NEUROPATHY 11 0.0253
12 ENCEPHALITIS TOXIC 2 0.0253
13 ALCOHOL TEST POSITIVE 1 0.0213
14 ACUTE MOTOR AXONAL NEUROPATHY 2 0.0192
15 NOCARDIA SEPSIS 1 0.0185
16 SUBENDOCARDIAL ISCHAEMIA 2 0.0180
17 MANIC SYMPTOM 3 0.0179
18 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 4 0.0174
19 VITAMIN B1 DECREASED 4 0.0159
20 ILLOGICAL THINKING 3 0.0159
21 CONFABULATION 4 0.0151
22 OBSESSIVE RUMINATION 1 0.0143
23 DISSOCIATIVE DISORDER 10 0.0139
24 ACIDOSIS HYPERCHLORAEMIC 8 0.0135
25 SINOBRONCHITIS 2 0.0134
26 JARISCH-HERXHEIMER REACTION 9 0.0126
27 OEDEMA DUE TO HEPATIC DISEASE 1 0.0125
28 REDUCED FACIAL EXPRESSION 12 0.0118
29 DYSKINESIA OESOPHAGEAL 1 0.0112
30 DILATED PORES 1 0.0110
31 NEONATAL RESPIRATORY DISTRESS 10 0.0106
32 GENITAL PARAESTHESIA 3 0.0103
33 DELUSION OF REPLACEMENT 1 0.0100
34 CARDIAC INDEX DECREASED 1 0.0097
35 MALE GENITAL ATROPHY 1 0.0093
36 METABOLIC ALKALOSIS 15 0.0093
37 ACUTE ON CHRONIC LIVER FAILURE 2 0.0093
38 NEUROENDOCRINE TUMOUR OF THE LUNG 1 0.0093
39 ALCOHOL WITHDRAWAL SYNDROME 8 0.0092
40 GAMMA-GLUTAMYLTRANSFERASE 1 0.0092
41 BLOOD LACTATE DEHYDROGENASE DECREASED 3 0.0090
42 ALCOHOL INTERACTION 17 0.0087
43 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 2 0.0087
44 MYOGLOBINAEMIA 1 0.0085
45 INJECTION SITE GRANULOMA 2 0.0084
46 NEUROBORRELIOSIS 1 0.0076
47 MYOCARDIAL STUNNING 1 0.0075
48 CALCIUM IONISED INCREASED 1 0.0072
49 TOXIC ENCEPHALOPATHY 36 0.0071
50 HYPOTENSIVE CRISIS 1 0.0069
51 BRUCELLOSIS 1 0.0066
52 HYPOTONIA NEONATAL 10 0.0064
53 PSYCHIATRIC SYMPTOM 44 0.0060
54 FOETAL CHROMOSOME ABNORMALITY 1 0.0059
55 HEPATITIS CHRONIC ACTIVE 1 0.0059
56 PH URINE INCREASED 1 0.0058
57 TRI-IODOTHYRONINE DECREASED 3 0.0057
58 DYSSOMNIA 1 0.0052
59 PSYCHOTIC BEHAVIOUR 5 0.0049
60 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 4 0.0049
61 THYROXINE DECREASED 3 0.0048
62 KUSSMAUL RESPIRATION 1 0.0048
63 INFLUENZA VIRUS TEST POSITIVE 1 0.0047
64 PREGNANCY WITH INJECTABLE CONTRACEPTIVE 1 0.0047
65 BELLIGERENCE 2 0.0047
66 BLOOD ETHANOL INCREASED 1 0.0045
67 BREATH ALCOHOL TEST POSITIVE 1 0.0044
68 ANTICHOLINERGIC SYNDROME 7 0.0044
69 LOCKED-IN SYNDROME 2 0.0043
70 HYPOGONADISM MALE 1 0.0043
71 CEREBRAL HYPOPERFUSION 2 0.0043
72 CEREBELLAR ATAXIA 4 0.0042
73 BLOOD BICARBONATE INCREASED 2 0.0042
74 PCO2 DECREASED 4 0.0041
75 MICROCYTOSIS 1 0.0040
76 METASTASES TO THORAX 1 0.0040
77 ANTIPSYCHOTIC DRUG LEVEL INCREASED 11 0.0039
78 HEPATIC TRAUMA 1 0.0039
79 AORTA HYPOPLASIA 1 0.0038
80 ENDOCARDITIS BACTERIAL 3 0.0038
81 HEMIANAESTHESIA 3 0.0038
82 FOETAL ARRHYTHMIA 1 0.0037
83 SPUTUM CULTURE POSITIVE 3 0.0037
84 PERIPHERAL MOTOR NEUROPATHY 5 0.0036
85 REPETITIVE SPEECH 2 0.0036
86 ACUTE POLYNEUROPATHY 1 0.0035
87 POST-INJECTION DELIRIUM SEDATION SYNDROME 3 0.0035
88 AVERSION 1 0.0035
89 AXONAL NEUROPATHY 3 0.0034
90 PRODUCT RECONSTITUTION ISSUE 1 0.0032
91 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 2 0.0031
92 HEPATITIS ALCOHOLIC 1 0.0031
93 METABOLIC SYNDROME 5 0.0030
94 CHOLURIA 1 0.0029
95 CRANIAL NERVE DISORDER 2 0.0029
96 FIBROUS HISTIOCYTOMA 1 0.0028
97 NEUROMUSCULAR TOXICITY 1 0.0028
98 ANTIDEPRESSANT DRUG LEVEL INCREASED 1 0.0028
99 ALKALOSIS 1 0.0026
100 MACROCYTOSIS 3 0.0026
101 ALCOHOLISM 11 0.0026
102 BLOOD ALCOHOL INCREASED 2 0.0026
103 LAGOPHTHALMOS 1 0.0024
104 HYPOMANIA 9 0.0024
105 PULMONARY CALCIFICATION 1 0.0024
106 LYME DISEASE 8 0.0024
107 DELUSIONAL DISORDER, PERSECUTORY TYPE 1 0.0024
108 ALVEOLAR OSTEITIS 1 0.0024
109 FRONTOTEMPORAL DEMENTIA 1 0.0023
110 FOOD INTERACTION 4 0.0023
111 CIRRHOSIS ALCOHOLIC 1 0.0022
112 PRIMARY BILIARY CHOLANGITIS 1 0.0021
113 PRE-EXISTING DISEASE 1 0.0021
114 IDIOSYNCRATIC DRUG REACTION 2 0.0020
115 HYPERCALCAEMIA 25 0.0020
116 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 1 0.0020
117 HEPATITIS ACUTE 13 0.0020
118 HYPOHIDROSIS 1 0.0020
119 PO2 INCREASED 1 0.0020
120 POLYCYTHAEMIA 4 0.0019
121 FOCAL NODULAR HYPERPLASIA 1 0.0019
122 MALE ORGASMIC DISORDER 1 0.0019
123 FRACTURE PAIN 1 0.0019
124 RESPIRATORY ALKALOSIS 3 0.0018
125 BRADYPHRENIA 12 0.0018
126 BLOOD PH INCREASED 1 0.0018
127 PRESBYOPIA 1 0.0018
128 BRAIN SCAN ABNORMAL 1 0.0018
129 NAIL DYSTROPHY 1 0.0018
130 DYSPRAXIA 1 0.0018
131 PO2 DECREASED 2 0.0017
132 FLASHBACK 1 0.0017
133 ISCHAEMIC CEREBRAL INFARCTION 2 0.0017
134 PROTRUSION TONGUE 1 0.0017
135 DISSOCIATION 13 0.0017
136 AMBLYOPIA 1 0.0017
137 ODYNOPHAGIA 10 0.0017
138 HYPOVOLAEMIC SHOCK 8 0.0017
139 HALLUCINATIONS, MIXED 7 0.0017
140 GENERALISED TONIC-CLONIC SEIZURE 27 0.0016
141 ALCOHOL USE 6 0.0016
142 PERIPHERAL SENSORIMOTOR NEUROPATHY 2 0.0016
143 ELECTROENCEPHALOGRAM ABNORMAL 5 0.0016
144 INJECTION SITE LACERATION 1 0.0016
145 PRESSURE OF SPEECH 1 0.0015
146 HEPATITIS TOXIC 4 0.0015
147 PSYCHOMOTOR SKILLS IMPAIRED 4 0.0015
148 CATATONIA 8 0.0015
149 COMPULSIONS 1 0.0015
150 CATARACT NUCLEAR 1 0.0015
151 ALCOHOL ABUSE 4 0.0015
152 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
153 CYTOKINE STORM 1 0.0015
154 FEELING OF RELAXATION 1 0.0015
155 PAINFUL ERECTION 1 0.0014
156 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 1 0.0014
157 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
158 OPTIC NEUROPATHY 3 0.0014
159 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 2 0.0014
160 PERIPHERAL SENSORY NEUROPATHY 8 0.0014
161 LEGAL PROBLEM 1 0.0014
162 COMA HEPATIC 1 0.0013
163 AMINO ACID LEVEL INCREASED 1 0.0013
164 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 3 0.0013
165 AMPHETAMINES POSITIVE 1 0.0013
166 MULTIPLE DRUG THERAPY 1 0.0013
167 HEPATIC NECROSIS 5 0.0013
168 MYOGLOBIN BLOOD INCREASED 2 0.0013
169 ELECTROCARDIOGRAM PR PROLONGATION 1 0.0013
170 METHAEMOGLOBINAEMIA 3 0.0013
171 CRITICAL ILLNESS 1 0.0013
172 SUBSTANCE USE 2 0.0013
173 CHRONIC ALLOGRAFT NEPHROPATHY 1 0.0013
174 DRUG-INDUCED LIVER INJURY 40 0.0013
175 MYOCLONUS 15 0.0013
176 POLYNEUROPATHY 15 0.0013
177 STUPOR 4 0.0012
178 DISINHIBITION 2 0.0012
179 INTERVERTEBRAL DISC SPACE NARROWING 1 0.0012
180 WRONG DOSE 3 0.0012
181 CHRONIC HEPATITIS 1 0.0012
182 PARKINSONISM 12 0.0012
183 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
184 MITOCHONDRIAL TOXICITY 1 0.0012
185 SOPOR 16 0.0012
186 QUADRIPARESIS 2 0.0012
187 NEUROLEPTIC MALIGNANT SYNDROME 14 0.0012
188 SEIZURE LIKE PHENOMENA 2 0.0012
189 SEDATION COMPLICATION 3 0.0012
190 NOCARDIOSIS 3 0.0012
191 HYPERAMMONAEMIC ENCEPHALOPATHY 2 0.0011
192 FOOD REFUSAL 1 0.0011
193 DRUG DETOXIFICATION 1 0.0011
194 VOCAL CORD PARALYSIS 2 0.0011
195 ENCEPHALOPATHY 27 0.0011
196 MANIA 18 0.0011
197 ABULIA 1 0.0011
198 BUNDLE BRANCH BLOCK 1 0.0011
199 PSYCHOTIC DISORDER 31 0.0010
200 CONCUSSION 8 0.0010
201 HYPOKINESIA 15 0.0010
202 ANIMAL SCRATCH 1 0.0010
203 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
204 HEPATITIS FULMINANT 3 0.0010
205 MIXED LIVER INJURY 3 0.0010
206 MUCOSAL DRYNESS 2 0.0010
207 DYSPHORIA 5 0.0010
208 INJECTION SITE NECROSIS 2 0.0010
209 BREAST ABSCESS 1 0.0010
210 NEUROTOXICITY 17 0.0010
211 IMPAIRED SELF-CARE 2 0.0010
212 POSTICTAL STATE 1 0.0010
213 AXILLARY MASS 1 0.0010
214 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
215 ASTERIXIS 1 0.0009
216 EXOPHTHALMOS 2 0.0009
217 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
218 INTENTIONAL SELF-INJURY 18 0.0009
219 CYTOGENETIC ABNORMALITY 1 0.0009
220 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
221 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
222 GRAND MAL CONVULSION 8 0.0009
223 LUMBAR RADICULOPATHY 1 0.0009
224 OSTEOCHONDROSIS 1 0.0009
225 HANGOVER 3 0.0009
226 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
227 DELUSION 13 0.0008
228 BONE LESION 3 0.0008
229 CARDIAC DEATH 1 0.0008
230 LIVER TRANSPLANT 3 0.0008
231 HYPERACUSIS 3 0.0008
232 THINKING ABNORMAL 15 0.0008
233 INJECTION SITE ABSCESS 2 0.0008
234 TACHYARRHYTHMIA 2 0.0008
235 POISONING 10 0.0008
236 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
237 INFUSION SITE IRRITATION 1 0.0008
238 GESTATIONAL HYPERTENSION 1 0.0008
239 DRUG INTERACTION 122 0.0008
240 ACQUIRED GENE MUTATION 1 0.0008
241 AREFLEXIA 2 0.0007
242 ANION GAP INCREASED 1 0.0007
243 ALCOHOL POISONING 2 0.0007
244 RESPIRATORY DEPRESSION 9 0.0007
245 CARBON DIOXIDE INCREASED 1 0.0007
246 ACUTE HEPATIC FAILURE 10 0.0007
247 AGORAPHOBIA 1 0.0007
248 CLONUS 2 0.0007
249 SELF-MEDICATION 3 0.0007
250 ACCIDENTAL POISONING 1 0.0007
251 DISCHARGE 1 0.0007
252 ELECTRIC SHOCK SENSATION 2 0.0007
253 BRONCHIAL OBSTRUCTION 1 0.0007
254 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
255 EJACULATION DISORDER 2 0.0007
256 PRECANCEROUS CELLS PRESENT 1 0.0007
257 PERONEAL NERVE PALSY 4 0.0007
258 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
259 HORDEOLUM 3 0.0007
260 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
261 OCULAR ICTERUS 3 0.0007
262 DELIRIUM 24 0.0007
263 METABOLIC ENCEPHALOPATHY 2 0.0007
264 MENTAL IMPAIRMENT 16 0.0007
265 MYOCLONIC EPILEPSY 1 0.0007
266 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
267 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
268 PORTAL HYPERTENSION 2 0.0006
269 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
270 PARANOIA 11 0.0006
271 MEGACOLON 1 0.0006
272 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
273 OPTIC NERVE DISORDER 1 0.0006
274 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
275 LISTLESS 2 0.0006
276 LIVER FUNCTION TEST INCREASED 13 0.0006
277 ILLUSION 1 0.0006
278 IGA NEPHROPATHY 1 0.0006
279 THERAPEUTIC AGENT TOXICITY 2 0.0006
280 SALIVARY HYPERSECRETION 6 0.0006
281 POTENTIATING DRUG INTERACTION 2 0.0006
282 ATAXIA 7 0.0006
283 FOOD AVERSION 1 0.0006
284 NEUROPATHY 1 0.0006
285 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 4 0.0006
286 HEPATIC FIBROSIS 2 0.0006
287 ANURIA 5 0.0006
288 DISORIENTATION 23 0.0006
289 PRODUCT COUNTERFEIT 1 0.0006
290 VIITH NERVE PARALYSIS 2 0.0006
291 BLOOD CHLORIDE INCREASED 1 0.0006
292 SLEEP APNOEA SYNDROME 11 0.0006
293 INFUSION SITE DISCHARGE 1 0.0006
294 SERUM FERRITIN INCREASED 3 0.0006
295 NECROTISING FASCIITIS 2 0.0006
296 NYSTAGMUS 3 0.0006
297 PARAPARESIS 1 0.0006
298 CONJUNCTIVAL HYPERAEMIA 2 0.0006
299 BLOOD HIV RNA INCREASED 1 0.0006
300 CONDUCTION DISORDER 1 0.0005
301 INTRACRANIAL PRESSURE INCREASED 3 0.0005
302 INJECTION SITE CELLULITIS 1 0.0005
303 KETOACIDOSIS 4 0.0005
304 NASAL OBSTRUCTION 1 0.0005
305 DYSARTHRIA 20 0.0005
306 DRUG ABUSE 44 0.0005
307 MYELOPATHY 1 0.0005
308 ACIDOSIS 4 0.0005
309 COMMUNICATION DISORDER 2 0.0005
310 SUICIDE ATTEMPT 31 0.0005
311 HEPATOMEGALY 5 0.0005
312 GENE MUTATION 1 0.0005
313 MENTAL STATUS CHANGES 14 0.0005
314 HEPATITIS CHOLESTATIC 3 0.0005
315 FOAMING AT MOUTH 1 0.0005
316 LIBIDO INCREASED 1 0.0005
317 EPILEPSY 15 0.0005
318 POLYURIA 4 0.0005
319 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2 0.0005
320 FEAR 13 0.0005
321 OLIGURIA 3 0.0005
322 CHEST INJURY 1 0.0005
323 BODY TEMPERATURE FLUCTUATION 1 0.0005
324 METABOLIC ACIDOSIS 15 0.0005
325 MYDRIASIS 6 0.0005
326 PANIC ATTACK 17 0.0005
327 HYPERPHOSPHATAEMIA 1 0.0005
328 HEPATIC FAILURE 14 0.0005
329 INCOHERENT 3 0.0005
330 JAW FRACTURE 1 0.0005
331 FACIAL PALSY 1 0.0005
332 URINE OUTPUT DECREASED 4 0.0005
333 NOSOCOMIAL INFECTION 1 0.0005
334 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
335 STEVENS-JOHNSON SYNDROME 10 0.0004
336 FAECES PALE 1 0.0004
337 PARESIS 1 0.0004
338 LARGE INTESTINAL OBSTRUCTION 1 0.0004
339 JAUNDICE 12 0.0004
340 FEAR OF DEATH 1 0.0004
341 HEPATOCELLULAR DAMAGE 1 0.0004
342 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
343 VASCULAR DEVICE INFECTION 2 0.0004
344 DRUG TOXICITY 6 0.0004
345 PNEUMONIA ASPIRATION 11 0.0004
346 URINE ABNORMALITY 2 0.0004
347 MYOCARDIAL ISCHAEMIA 5 0.0004
348 DENGUE FEVER 1 0.0004
349 RESPIRATORY ARREST 12 0.0004
350 COORDINATION ABNORMAL 6 0.0004
351 HEPATIC ENCEPHALOPATHY 4 0.0004
352 YELLOW SKIN 2 0.0004
353 DYSMORPHISM 1 0.0004
354 SINUS TACHYCARDIA 6 0.0004
355 PRODUCT PRESCRIBING ERROR 10 0.0004
356 LACUNAR INFARCTION 1 0.0004
357 SEROTONIN SYNDROME 8 0.0004
358 ORAL INTAKE REDUCED 1 0.0004
359 MAJOR DEPRESSION 3 0.0004
360 BREATH ODOUR 1 0.0004
361 CEREBRAL DISORDER 3 0.0004
362 ACUTE PSYCHOSIS 1 0.0004
363 MULTIPLE DRUG OVERDOSE 2 0.0004
364 INJECTION SITE INFLAMMATION 2 0.0004
365 PREMATURE BABY 12 0.0004
366 EXPOSURE VIA INGESTION 1 0.0004
367 DIABETIC COMPLICATION 1 0.0004
368 AMMONIA INCREASED 2 0.0004
369 ANGLE CLOSURE GLAUCOMA 1 0.0004
370 EUPHORIC MOOD 4 0.0004
371 ENDOCARDITIS 2 0.0004
372 DISTURBANCE IN ATTENTION 21 0.0004
373 PHYSICAL DECONDITIONING 1 0.0004
374 TOXICITY TO VARIOUS AGENTS 65 0.0004
375 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
376 AFFECTIVE DISORDER 3 0.0004
377 DRUG SCREEN POSITIVE 3 0.0004
378 MIOSIS 3 0.0004
379 ANAESTHETIC COMPLICATION 1 0.0004
380 CLUMSINESS 1 0.0004
381 CHOKING SENSATION 2 0.0004
382 DRUG LEVEL INCREASED 6 0.0004
383 ACUTE CORONARY SYNDROME 3 0.0004
384 RHABDOMYOLYSIS 15 0.0004
385 DEPRESSED MOOD 19 0.0004
386 HAEMODIALYSIS 3 0.0004
387 PSYCHOMOTOR RETARDATION 1 0.0004
388 PANCREATIC CARCINOMA METASTATIC 1 0.0004
389 GRANULOCYTOPENIA 2 0.0004
390 DRUG RESISTANCE 9 0.0004
391 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
392 CARDIOGENIC SHOCK 5 0.0003
393 NEUROPATHY PERIPHERAL 33 0.0003
394 MENTAL DISORDER 15 0.0003
395 NECK INJURY 1 0.0003
396 BONE MARROW DISORDER 1 0.0003
397 AGITATION 24 0.0003
398 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
399 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
400 FIBROSIS 1 0.0003
401 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
402 FAECES DISCOLOURED 7 0.0003
403 INJECTION SITE HYPERSENSITIVITY 1 0.0003
404 SUICIDAL IDEATION 29 0.0003
405 BREAST CANCER RECURRENT 1 0.0003
406 MULTIPLE DRUG OVERDOSE INTENTIONAL 1 0.0003
407 DYSTONIA 6 0.0003
408 LACTIC ACIDOSIS 10 0.0003
409 VITAMIN D DEFICIENCY 3 0.0003
410 OEDEMA MOUTH 1 0.0003
411 RENAL TUBULAR NECROSIS 3 0.0003
412 SEDATION 8 0.0003
413 DEAFNESS NEUROSENSORY 1 0.0003
414 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
415 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
416 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
417 BRAIN INJURY 3 0.0003
418 POST-TRAUMATIC STRESS DISORDER 2 0.0003
419 METASTASES TO SPINE 1 0.0003
420 CONFUSIONAL STATE 48 0.0003
421 HYPOTHERMIA 3 0.0003
422 DIABETIC RETINOPATHY 1 0.0003
423 MOTOR DYSFUNCTION 3 0.0003
424 COMA 14 0.0003
425 CIRCULATORY COLLAPSE 5 0.0003
426 AKATHISIA 4 0.0003
427 BLOOD TESTOSTERONE DECREASED 2 0.0003
428 INITIAL INSOMNIA 3 0.0003
429 DIFFICULTY IN WALKING 1 0.0003
430 LEFT VENTRICULAR FAILURE 1 0.0003
431 MULTI-ORGAN FAILURE 5 0.0003
432 DEPRESSION SUICIDAL 1 0.0003
433 HYPERREFLEXIA 1 0.0003
434 CAROTID ARTERY STENOSIS 1 0.0003
435 LIVER INJURY 7 0.0003
436 JAUNDICE CHOLESTATIC 1 0.0003
437 FACIAL PARESIS 1 0.0003
438 INTENTIONAL OVERDOSE 18 0.0003
439 COGNITIVE DISORDER 13 0.0003
440 PARADOXICAL DRUG REACTION 1 0.0003
441 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
442 CARDIAC DYSFUNCTION 1 0.0003
443 MALNUTRITION 3 0.0003
444 HEPATIC CIRRHOSIS 5 0.0003
445 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
446 TROPONIN INCREASED 2 0.0003
447 CONVULSION 15 0.0003
448 HYPERTHERMIA 2 0.0003
449 PROCEDURAL COMPLICATION 2 0.0003
450 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
451 ELECTROLYTE IMBALANCE 3 0.0003
452 POLYDIPSIA 1 0.0003
453 ABNORMAL BEHAVIOUR 10 0.0003
454 HALLUCINATION, AUDITORY 4 0.0003
455 OESOPHAGEAL CANDIDIASIS 1 0.0003
456 INTRACRANIAL ANEURYSM 1 0.0002
457 ENURESIS 1 0.0002
458 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
459 HYPERURICAEMIA 1 0.0002
460 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
461 COAGULOPATHY 4 0.0002
462 CONGESTIVE CARDIOMYOPATHY 1 0.0002
463 CARDIO-RESPIRATORY ARREST 10 0.0002
464 ERECTION INCREASED 1 0.0002
465 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
466 POOR PERIPHERAL CIRCULATION 1 0.0002
467 FACIAL PARALYSIS 2 0.0002
468 HEPATIC PAIN 1 0.0002
469 IRRITABILITY 14 0.0002
470 CARDIAC ARREST 19 0.0002
471 SYNCOPE 23 0.0002
472 PRODUCT DISPENSING ERROR 5 0.0002
473 DYSPHEMIA 1 0.0002
474 COMPLETED SUICIDE 19 0.0002
475 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
476 PURPURA 2 0.0002
477 BLOOD CREATINE INCREASED 1 0.0002
478 DRUG ERUPTION 4 0.0002
479 RESPIRATORY RATE INCREASED 2 0.0002
480 TRANSAMINASES INCREASED 5 0.0002
481 CARDIOTOXICITY 2 0.0002
482 ISCHAEMIC STROKE 4 0.0002
483 ACUTE KIDNEY INJURY 34 0.0002
484 TACHYPNOEA 3 0.0002
485 OPTIC NEURITIS 2 0.0002
486 PERIPHERAL COLDNESS 3 0.0002
487 EAR DISORDER 1 0.0002
488 ISCHAEMIA 1 0.0002
489 SHOCK 5 0.0002
490 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
491 NEPHROGENIC ANAEMIA 1 0.0002
492 PRODUCT DISTRIBUTION ISSUE 2 0.0002
493 PERFORMANCE STATUS DECREASED 1 0.0002
494 RENAL FAILURE ACUTE 9 0.0002
495 DIALYSIS 3 0.0002
496 POISONING DELIBERATE 2 0.0002
497 GESTATIONAL DIABETES 1 0.0002
498 AFFECT LABILITY 2 0.0002
499 APHAGIA 1 0.0002
500 INJECTION SITE HAEMATOMA 3 0.0002
501 GUILLAIN-BARRE SYNDROME 1 0.0002
502 APATHY 3 0.0002
503 OVERDOSE 44 0.0002
504 BODY TEMPERATURE DECREASED 2 0.0002
505 TACHYCARDIA 18 0.0002
506 ANEURYSM 1 0.0002
507 APHASIA 6 0.0002
508 OSTEOPENIA 3 0.0002
509 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
510 HYPONATRAEMIA 11 0.0002
511 EAR DISCOMFORT 2 0.0002
512 MUSCULOSKELETAL CHEST PAIN 3 0.0002
513 TREMOR 32 0.0002
514 APLASTIC ANAEMIA 1 0.0002
515 SPEECH DISORDER 10 0.0002
516 HEPATIC ENZYME INCREASED 13 0.0002
517 INCONTINENCE 2 0.0002
518 INJECTION SITE REACTION 13 0.0002
519 IMPAIRED WORK ABILITY 4 0.0002
520 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
521 GINGIVITIS 1 0.0002
522 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
523 HYDROCEPHALUS 1 0.0002
524 OESOPHAGITIS 2 0.0002
525 ASPIRATION 2 0.0002
526 STAPHYLOCOCCAL INFECTION 6 0.0002
527 INTESTINAL ISCHAEMIA 1 0.0002
528 HEPATOTOXICITY 4 0.0002
529 SOMNOLENCE 36 0.0002
530 ANGIOPATHY 1 0.0002
531 HEMIPARESIS 3 0.0002
532 STATUS EPILEPTICUS 2 0.0002
533 MITRAL VALVE INCOMPETENCE 2 0.0002
534 GENERALISED ERYTHEMA 1 0.0002
535 DERMATITIS CONTACT 2 0.0002
536 MYOCARDITIS 2 0.0002
537 LETHARGY 10 0.0002
538 EXERCISE TOLERANCE DECREASED 1 0.0002
539 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
540 METABOLIC DISORDER 1 0.0002
541 HYPOVOLAEMIA 1 0.0002
542 SEXUAL DYSFUNCTION 2 0.0002
543 DECREASED INTEREST 1 0.0002
544 LEUKOCYTOSIS 3 0.0002
545 HEPATITIS C 2 0.0002
546 HYPOGLYCAEMIA 8 0.0002
547 SCHIZOPHRENIA 2 0.0002
548 RESPIRATORY FAILURE 12 0.0002
549 TREATMENT NONCOMPLIANCE 9 0.0002
550 SEIZURE 19 0.0002
551 CEREBRAL INFARCTION 4 0.0002
552 CARDIOMEGALY 2 0.0002
553 LARYNGEAL OEDEMA 1 0.0002
554 INJECTION SITE MASS 6 0.0002
555 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
556 CONJUNCTIVITIS 3 0.0002
557 EXTRAPYRAMIDAL DISORDER 4 0.0002
558 NERVOUS SYSTEM DISORDER 5 0.0002
559 MEMORY IMPAIRMENT 22 0.0002
560 BLEPHAROSPASM 1 0.0002
561 MULTIPLE INJURIES 1 0.0002
562 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
563 ERECTILE DYSFUNCTION 4 0.0002
564 INJECTION SITE INDURATION 2 0.0002
565 DIPLOPIA 4 0.0002
566 NODULE 2 0.0002
567 PRODUCT PREPARATION ISSUE 1 0.0002
568 GASTRITIS 4 0.0002
569 DYSGRAPHIA 1 0.0002
570 PULMONARY CONGESTION 2 0.0002
571 ANXIETY 43 0.0002
572 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
573 APPETITE DISORDER 1 0.0002
574 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
575 QUALITY OF LIFE DECREASED 2 0.0001
576 METASTASES TO LYMPH NODES 1 0.0001
577 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
578 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
579 DROOLING 1 0.0001
580 HYPERTRANSAMINASAEMIA 1 0.0001
581 FORMICATION 1 0.0001
582 HUNGER 2 0.0001
583 INTENTIONAL DRUG MISUSE 3 0.0001
584 ROAD TRAFFIC ACCIDENT 6 0.0001
585 HYPERKALAEMIA 5 0.0001
586 OFF LABEL USE 124 0.0001
587 EATING DISORDER 3 0.0001
588 BRONCHOSPASM 2 0.0001
589 AGGRESSION 7 0.0001
590 PARALYSIS 2 0.0001
591 IMPAIRED QUALITY OF LIFE 2 0.0001
592 PARAESTHESIA ORAL 2 0.0001
593 DERMATITIS BULLOUS 1 0.0001
594 BLINDNESS TRANSIENT 1 0.0001
595 HYPOPHOSPHATAEMIA 1 0.0001
596 URINARY INCONTINENCE 4 0.0001
597 ARTHROPOD BITE 1 0.0001
598 RASH MACULO-PAPULAR 3 0.0001
599 HEPATIC FUNCTION ABNORMAL 5 0.0001
600 CHROMATURIA 3 0.0001
601 LOSS OF CONSCIOUSNESS 17 0.0001
602 PAROSMIA 1 0.0001
603 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
604 AORTIC ANEURYSM 1 0.0001
605 HAEMODYNAMIC INSTABILITY 1 0.0001
606 MUSCLE TWITCHING 3 0.0001
607 PHARYNGEAL OEDEMA 2 0.0001
608 ATRIOVENTRICULAR BLOCK 1 0.0001
609 APHTHOUS ULCER 1 0.0001
610 CYANOSIS 2 0.0001
611 NASAL DISCOMFORT 1 0.0001
612 BLOOD ALBUMIN DECREASED 1 0.0001
613 LOW BIRTH WEIGHT BABY 1 0.0001
614 HYPOTENSION 25 0.0001
615 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
616 MUSCLE DISORDER 1 0.0001
617 MUSCLE TIGHTNESS 2 0.0001
618 POST PROCEDURAL INFECTION 1 0.0001
619 AMNESIA 8 0.0001
620 BLOOD CREATININE INCREASED 8 0.0001
621 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
622 HEMIPLEGIA 1 0.0001
623 INSOMNIA 32 0.0001
624 BLOOD UREA INCREASED 2 0.0001
625 CONDITION AGGRAVATED 36 0.0001
626 HAEMATEMESIS 3 0.0001
627 INADEQUATE ANALGESIA 1 0.0001
628 UNRESPONSIVE TO STIMULI 3 0.0001
629 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
630 DRUG WITHDRAWAL SYNDROME 10 0.0001
631 PRODUCT COMMUNICATION ISSUE 1 0.0001
632 HEAD DISCOMFORT 2 0.0001
633 LIVER DISORDER 5 0.0001
634 THIRST 2 0.0001
635 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
636 LOSS OF LIBIDO 1 0.0001
637 ANAL INCONTINENCE 1 0.0001
638 PALLOR 3 0.0001
639 DEPRESSION 25 0.0001
640 ACCIDENTAL OVERDOSE 4 0.0001
641 RESPIRATORY DISTRESS 3 0.0001
642 BLOOD GLUCOSE ABNORMAL 2 0.0001
643 PERSONALITY CHANGE 1 0.0001
644 AGRANULOCYTOSIS 2 0.0001
645 HEPATIC STEATOSIS 2 0.0001
646 BACTERIAL INFECTION 2 0.0001
647 MIDDLE INSOMNIA 2 0.0001
648 FLANK PAIN 1 0.0001
649 FATIGUE 83 0.0001
650 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
651 CHOLESTASIS 2 0.0001
652 NEEDLE ISSUE 3 0.0001
653 DYSSTASIA 3 0.0001
654 HEART RATE INCREASED 10 0.0001
655 BLADDER DISORDER 1 0.0001
656 HYPOTONIA 1 0.0001
657 OVARIAN CYST 1 0.0001
658 THERAPEUTIC RESPONSE DECREASED 6 0.0001
659 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
660 BODY TEMPERATURE INCREASED 2 0.0001
661 NEUTROPHIL COUNT INCREASED 1 0.0001
662 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
663 DEHYDRATION 13 0.0001
664 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
665 INJECTION SITE WARMTH 2 0.0001
666 POOR VENOUS ACCESS 1 0.0001
667 HYPERBILIRUBINAEMIA 1 0.0001
668 INJECTION SITE DISCOMFORT 1 0.0001
669 HEAD INJURY 3 0.0001
670 HALLUCINATION, VISUAL 2 0.0001
671 MYALGIA 16 0.0001
672 MOVEMENT DISORDER 3 0.0001
673 HEREDITARY ANGIOEDEMA 1 0.0001
674 HYPERHIDROSIS 12 0.0001
675 DECREASED ACTIVITY 1 0.0001
676 PHARYNGITIS STREPTOCOCCAL 1 0.0001
677 BACK INJURY 1 0.0001
678 INTENTIONAL PRODUCT MISUSE 8 0.0001
679 DENTAL CARIES 1 0.0001
680 ABDOMINAL PAIN 21 0.0001
681 NERVE INJURY 1 0.0001
682 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
683 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
684 FLUSHING 9 0.0001
685 IMPAIRED DRIVING ABILITY 1 0.0001
686 TINNITUS 4 0.0001
687 NIGHTMARE 3 0.0001
688 METASTASES TO LUNG 1 0.0001
689 HYPOXIA 3 0.0001
690 INFLUENZA LIKE ILLNESS 7 0.0001
691 CHOLECYSTITIS 1 0.0001
692 ACCIDENT 1 0.0001
693 HYPERLIPIDAEMIA 1 0.0001
694 MUSCLE RIGIDITY 1 0.0001
695 BLOOD PRESSURE FLUCTUATION 2 0.0001
696 DIABETIC KETOACIDOSIS 2 0.0001
697 RENAL FAILURE 11 0.0001
698 LOCALISED INFECTION 2 0.0001
699 C-REACTIVE PROTEIN INCREASED 3 0.0001
700 ASTHENIA 31 0.0001
701 PRESYNCOPE 2 0.0001
702 VERTIGO 5 0.0001
703 NO THERAPEUTIC RESPONSE 1 0.0001
704 INJECTION SITE EXTRAVASATION 1 0.0001
705 OSTEONECROSIS OF JAW 2 0.0001
706 MUSCLE ATROPHY 1 0.0001
707 INFUSION SITE PAIN 1 0.0001
708 ANOREXIA 1 0.0001
709 ANAPHYLACTIC SHOCK 2 0.0001
710 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
711 DECREASED APPETITE 18 0.0001
712 SWELLING FACE 5 0.0001
713 RESPIRATORY TRACT INFECTION 2 0.0001
714 ANHEDONIA 2 0.0001
715 OROPHARYNGEAL PAIN 7 0.0001
716 ADVERSE REACTION 1 0.0001
717 BLOOD PRESSURE DECREASED 5 0.0001
718 MALAISE 33 0.0001
719 PNEUMONITIS 2 0.0001
720 MOOD ALTERED 2 0.0001
721 CORONARY ARTERY OCCLUSION 1 0.0001
722 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
723 APPLICATION SITE RASH 1 0.0001
724 VOMITING 34 0.0001
725 HYPOMAGNESAEMIA 1 0.0001
726 WOUND 2 0.0001
727 MASS 1 0.0001
728 WITHDRAWAL SYNDROME 3 0.0001
729 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
730 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
731 HYPOACUSIS 3 0.0001
732 ACCIDENTAL UNDERDOSE 1 0.0001
733 SEPTIC SHOCK 3 0.0001
734 DYSPHONIA 4 0.0001
735 SURGERY 4 0.0001
736 ANAEMIA 13 0.0001
737 DISEASE PROGRESSION 8 0.0001
738 PULMONARY MASS 1 0.0001
739 IMMUNODEFICIENCY 1 0.0001
740 THERAPY NON-RESPONDER 3 0.0001
741 HYPOAESTHESIA ORAL 1 0.0001
742 LACRIMATION INCREASED 2 0.0001
743 ECONOMIC PROBLEM 1 0.0001
744 NAUSEA 52 0.0001
745 INSURANCE ISSUE 1 0.0001
746 HIP ARTHROPLASTY 1 0.0001
747 DRUG ADMINISTRATION ERROR 2 0.0001
748 ANKLE FRACTURE 1 0.0001
749 EJECTION FRACTION DECREASED 1 0.0001
750 SWOLLEN TONGUE 2 0.0001
751 BRAIN FOG 1 0.0001
752 ARRHYTHMIA 3 0.0001
753 DYSPHAGIA 6 0.0001
754 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
755 DISEASE RECURRENCE 3 0.0001
756 OBESITY 1 0.0001
757 GAIT DISTURBANCE 12 0.0001
758 DRUG DEPENDENCE 10 0.0001
759 NIGHT SWEATS 2 0.0001
760 ATRIAL FIBRILLATION 6 0.0001
761 BLOOD POTASSIUM INCREASED 1 0.0001
762 DEEP VEIN THROMBOSIS 4 0.0001
763 HYPERTENSION 13 0.0001
764 CHOLELITHIASIS 2 0.0001
765 METASTASES TO BONE 1 0.0001
766 EYE DISORDER 2 0.0001
767 INFUSION RELATED REACTION 4 0.0001
768 LIP SWELLING 2 0.0001
769 FUNGAL INFECTION 2 0.0001
770 GAIT INABILITY 2 0.0001
771 THERAPY CESSATION 3 0.0001
772 MUSCULOSKELETAL DISCOMFORT 1 0.0001
773 NEOPLASM PROGRESSION 2 0.0001
774 ORTHOSTATIC HYPOTENSION 1 0.0001
775 METASTASES TO LIVER 1 0.0001
776 COLD SWEAT 1 0.0001
777 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
778 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
779 GALLBLADDER DISORDER 1 0.0001
780 GOUT 1 0.0001
781 END STAGE RENAL DISEASE 1 0.0001
782 RESTLESSNESS 2 0.0001
783 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
784 DIZZINESS 27 0.0001
785 NECK PAIN 3 0.0001
786 HYPOAESTHESIA 8 0.0001
787 PRODUCT USE ISSUE 10 0.0001
788 DYSPNOEA EXERTIONAL 2 0.0001
789 HALLUCINATION 4 0.0001
790 BLOOD SODIUM DECREASED 1 0.0001
791 FRACTURE 1 0.0001
792 CHRONIC KIDNEY DISEASE 4 0.0001
793 PROTEINURIA 1 0.0001
794 INCREASED APPETITE 1 0.0001
795 BLOOD PRESSURE INCREASED 8 0.0001
796 PULMONARY FIBROSIS 1 0.0001
797 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
798 PRODUCT SUBSTITUTION ISSUE 3 0.0001
799 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
800 PRESCRIBED OVERDOSE 1 0.0001
801 EAR PAIN 1 0.0001
802 CHILLS 6 0.0001
803 VISION BLURRED 7 0.0001
804 PARAESTHESIA 8 0.0001
805 DRUG INEFFECTIVE 67 0.0001
806 WHEEZING 3 0.0001
807 DISABILITY 1 0.0001
808 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
809 BLOOD PRESSURE ABNORMAL 1 0.0001
810 WEIGHT DECREASED 14 0.0001
811 FEELING ABNORMAL 12 0.0001
812 PREGNANCY 1 0.0000
813 PRODUCT ADMINISTRATION ERROR 1 0.0000
814 PRURITUS 19 0.0000
815 FEEDING DISORDER 1 0.0000
816 DYSKINESIA 2 0.0000
817 DISCOMFORT 3 0.0000
818 NEUTROPHIL COUNT DECREASED 2 0.0000
819 HAEMOGLOBIN DECREASED 5 0.0000
820 PRODUCT PREPARATION ERROR 1 0.0000
821 ERYTHEMA 10 0.0000
822 CHEST PAIN 9 0.0000
823 ILLNESS 5 0.0000
824 VISUAL IMPAIRMENT 6 0.0000
825 FALL 16 0.0000
826 ABDOMINAL DISTENSION 5 0.0000
827 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
828 OSTEOARTHRITIS 2 0.0000
829 POOR QUALITY SLEEP 1 0.0000
830 PRURITUS GENERALISED 1 0.0000
831 VAGINAL HAEMORRHAGE 2 0.0000
832 CONSTIPATION 10 0.0000
833 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
834 ARTHRALGIA 19 0.0000
835 MUSCULOSKELETAL STIFFNESS 4 0.0000
836 GLOSSODYNIA 1 0.0000
837 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
838 MUSCULAR WEAKNESS 5 0.0000
839 PRODUCT AVAILABILITY ISSUE 1 0.0000
840 NEPHROLITHIASIS 2 0.0000
841 HYPOKALAEMIA 2 0.0000
842 RENAL DISORDER 2 0.0000
843 INJURY 3 0.0000
844 PULMONARY EMBOLISM 4 0.0000
845 MULTIPLE SCLEROSIS 2 0.0000
846 MOBILITY DECREASED 3 0.0000
847 HEADACHE 26 0.0000
848 DRUG INTOLERANCE 4 0.0000
849 NEURALGIA 1 0.0000
850 URINARY TRACT INFECTION 7 0.0000
851 LUNG DISORDER 2 0.0000
852 BRONCHITIS 3 0.0000
853 ABASIA 1 0.0000
854 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
855 AGEUSIA 1 0.0000
856 CELLULITIS 2 0.0000
857 UNEVALUABLE EVENT 3 0.0000
858 DIABETES MELLITUS 3 0.0000
859 HEPATITIS 1 0.0000
860 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
861 ECZEMA 2 0.0000
862 MUCOSAL INFLAMMATION 1 0.0000
863 MUSCULOSKELETAL PAIN 2 0.0000
864 BRADYCARDIA 2 0.0000
865 THROMBOSIS 3 0.0000
866 PAIN OF SKIN 1 0.0000
867 DRUG EFFECT DECREASED 2 0.0000
868 BLOOD BILIRUBIN INCREASED 1 0.0000
869 DRY MOUTH 3 0.0000
870 OEDEMA 2 0.0000
871 ABNORMAL DREAMS 1 0.0000
872 ANAPHYLACTIC REACTION 2 0.0000
873 PROCEDURAL PAIN 1 0.0000
874 FEELING COLD 1 0.0000
875 PANCYTOPENIA 2 0.0000
876 DIARRHOEA 23 0.0000
877 OXYGEN SATURATION DECREASED 2 0.0000
878 PAIN IN JAW 1 0.0000
879 INCORRECT DOSE ADMINISTERED 8 0.0000
880 HYPERSOMNIA 1 0.0000
881 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
882 LIVER FUNCTION TEST ABNORMAL 1 0.0000
883 PALPITATIONS 4 0.0000
884 BONE PAIN 2 0.0000
885 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
886 ASCITES 1 0.0000
887 ACUTE MYOCARDIAL INFARCTION 1 0.0000
888 CATARACT 2 0.0000
889 ADVERSE DRUG REACTION 3 0.0000
890 INJECTION SITE RASH 1 0.0000
891 EMOTIONAL DISORDER 1 0.0000
892 EXPOSURE DURING PREGNANCY 2 0.0000
893 SWELLING 3 0.0000
894 MIGRAINE 3 0.0000
895 HYPOTHYROIDISM 1 0.0000
896 WEIGHT INCREASED 7 0.0000
897 DYSPEPSIA 3 0.0000
898 IMPAIRED HEALING 1 0.0000
899 DYSPNOEA 17 0.0000
900 NEOPLASM MALIGNANT 2 0.0000
901 INJECTION SITE PRURITUS 2 0.0000
902 ABDOMINAL DISCOMFORT 5 0.0000
903 EYE PRURITUS 1 0.0000
904 NEUTROPENIA 4 0.0000
905 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
906 HAEMATURIA 1 0.0000
907 PYREXIA 10 0.0000
908 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
909 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
910 CEREBRAL HAEMORRHAGE 1 0.0000
911 PNEUMONIA 9 0.0000
912 PAIN 17 0.0000
913 MUSCLE SPASMS 5 0.0000
914 DYSURIA 1 0.0000
915 PAIN IN EXTREMITY 8 0.0000
916 THROMBOCYTOPENIA 3 0.0000
917 EPISTAXIS 2 0.0000
918 HOT FLUSH 2 0.0000
919 INJECTION SITE SWELLING 2 0.0000
920 INJECTION SITE PAIN 8 0.0000
921 INJECTION SITE HAEMORRHAGE 2 0.0000
922 ABORTION SPONTANEOUS 1 0.0000
923 JOINT SWELLING 3 0.0000
924 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
925 PSORIATIC ARTHROPATHY 1 0.0000
926 BLINDNESS 1 0.0000
927 TREATMENT FAILURE 2 0.0000
928 POLLAKIURIA 1 0.0000
929 RENAL IMPAIRMENT 2 0.0000
930 SKIN EXFOLIATION 2 0.0000
931 CEREBROVASCULAR ACCIDENT 4 0.0000
932 MYOCARDIAL INFARCTION 4 0.0000
933 COVID-19 4 0.0000
934 ANGIOEDEMA 1 0.0000
935 COLITIS ULCERATIVE 1 0.0000
936 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
937 PRODUCT QUALITY ISSUE 3 0.0000
938 DEATH 19 0.0000
939 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
940 ADVERSE EVENT 2 0.0000
941 HYPERSENSITIVITY 4 0.0000
942 BACK PAIN 5 0.0000
943 CARDIAC DISORDER 2 0.0000
944 PRODUCTIVE COUGH 1 0.0000
945 BLOOD GLUCOSE DECREASED 1 0.0000
946 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
947 INFECTION 3 0.0000
948 RASH 9 0.0000
949 PRODUCT DOSE OMISSION ISSUE 6 0.0000
950 DRY EYE 1 0.0000
951 LEUKOPENIA 1 0.0000
952 CHEST DISCOMFORT 2 0.0000
953 PERIPHERAL SWELLING 3 0.0000
954 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
955 PANCREATITIS 1 0.0000
956 PLATELET COUNT DECREASED 2 0.0000
957 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
958 DEPENDENCE 1 0.0000
959 ARTHROPATHY 1 0.0000
960 INFLUENZA 2 0.0000
961 BLISTER 1 0.0000
962 HERPES ZOSTER 1 0.0000
963 EYE IRRITATION 1 0.0000
964 NASAL CONGESTION 1 0.0000
965 EMOTIONAL DISTRESS 2 0.0000
966 ILL-DEFINED DISORDER 1 0.0000
967 PLEURAL EFFUSION 1 0.0000
968 FEELING HOT 1 0.0000
969 NASOPHARYNGITIS 3 0.0000
970 INJECTION SITE ERYTHEMA 2 0.0000
971 PRODUCT DOSE OMISSION 1 0.0000
972 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
973 DYSGEUSIA 1 0.0000
974 ACNE 1 0.0000
975 HOSPITALISATION 2 0.0000
976 INJECTION SITE BRUISING 1 0.0000
977 CARDIAC FAILURE 1 0.0000
978 CARDIAC FAILURE CONGESTIVE 1 0.0000
979 DRUG DOSE OMISSION 2 0.0000
980 BALANCE DISORDER 1 0.0000
981 NO ADVERSE EVENT 2 0.0000
982 BREAST CANCER 1 0.0000
983 COUGH 3 0.0000
984 BLOOD GLUCOSE INCREASED 2 0.0000
985 ABDOMINAL PAIN UPPER 2 0.0000
986 ASTHMA 1 0.0000
987 OEDEMA PERIPHERAL 1 0.0000
988 PSORIASIS 1 0.0000
989 ALOPECIA 1 0.0000